Primary hyperaldosteronism resident survival guide: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 52: Line 52:
{{familytree | |!| | | |!| | |M01| |M02| |!| | | | |M01= > 35 years consider|M02= < 35 years consider|}}
{{familytree | |!| | | |!| | |M01| |M02| |!| | | | |M01= > 35 years consider|M02= < 35 years consider|}}
{{familytree | |!| | | |!| | |!| | | |!| | | |!| | | |}}
{{familytree | |!| | | |!| | |!| | | |!| | | |!| | | |}}
{{familytree |N01| | |N02|N03| |N04| |N05| | | |N01=• Glucocorticoid-remediable aldosteronism (GRA)<br> •Idiopathic hyperaldosteronism|N02= Adrenal Venous Sampling|N03= Adrenal Venous Sampling|N04=Aldosterone Producing Adenoma (APA) or Primary Adrenal Hyperplasia (PAH):<br> Unilateral laproscopic adrenalectomy|N05= Pharmacological therapy|}}
{{familytree |N01| |N02|-|N03| |N04| |N05| | | |N01=• Glucocorticoid-remediable aldosteronism (GRA) OR Idiopathic hyperaldosteronism:<br>• Pharmacologic therapy|N02= Adrenal Venous Sampling|N03= Adrenal Venous Sampling|N04=Aldosterone Producing Adenoma (APA) or Primary Adrenal Hyperplasia (PAH):<br> Unilateral laproscopic adrenalectomy|N05= Pharmacological therapy|}}

Revision as of 15:26, 18 July 2017

Template:Primary hyperladosteronism Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]

Overview

Causes

Common Causes

Common causes of Conn's Syndrome may be divided into:

  • Adrenal causes:
    • Aldosterone-secreting adrenal adenoma (APA-benign tumor, 50-60%)
    • Idiopathic hyperaldosteronism (IHA-Bilateral hyperplasia of the adrenal gland, 40-50%)
  • Extra-adrenal causes
    • Ectopic secretion of aldosterone (Ovaries and Kidneys)

Less Common Causes

  • Familial hyperaldosteronism type I (glucocorticoid-remediable aldosteronism [GRA])
  • Familial hyperaldosteronism II (the familial occurrence of APA or bilateral idiopathic hyperplasia or both)
  • Familial hyperaldosteronism type III (associated with the germline mutation in the KCNJ5 potassium channel)
  • Pure aldosterone-producing adrenocortical carcinomas
  • Unilateral adrenal hyperplasia

Diagnosis and Treatment

 
 
 
 
 
 
 
 
 
 
 
Preferred screening population:

• Blood pressure > 160 / 100 particularly (< 50 years)
• Resistant hypertension or refractory hypertension (use of > 3 anti-hypertensives and poor control of blood pressure)
• Hypokalemia (provoked by diuretic therapy or unprovoked)
• Hypertension and incidentally discovered adrenal adenoma
• Hypertension with a family history of early-onset hypertension (< 20 years) or cerebrovascular accident at age less than 40 years

• Hypertensive first-degree relatives of patients with PA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plasma Renin Activity/Aldosterone Ratio
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal or High Renin (Plasma Renin/Aldosterone ratio <10
 
 
 
 
 
 
 
 
 
 
 
Suppressed Renin (Plasma Renin/Aldosterone ratio >20
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
•Renin-secreting tumors
•Diuretic use
•Renovascular hypertension
•Coarctation of aorta
•Malignant phase hypertension
 
 
 
 
 
 
 
 
 
 
 
Urinary aldosterone
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Elevated
 
 
 
 
 
 
 
Normal
 
 
Low
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conn's syndrome (Primary aldosteronism)
 
 
 
 
 
 
 
Profound K+ depletion
 
 
• 17 alpha hydroxylase deficiency
• 11 beta hydroxylase deficiency
• Liddle's syndrome
• Licorice ingestion
•Deoxycorticosterone producing tumor
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Do confirmatory tests:
•Fludrocortisone supression test (Positive test= Aldosterone > 6 ng / dl and simultaneous PRA levels < than 1.0 ng / ml / hour)
OR
•Intravenous saline load testing (Positive test= Aldosterone more than 10 ng / dl)
OR
•Oral sodium loading test (Positive test= 24-hour urinary aldosterone excretion > 12 μg / day
OR
•Captopril challenge test (Positive test= PAC / PRA > 30, measured two hours after the administration of 25 mg or 50 mg of captopril)
 
 
 
 
 
 
 
 
 
 
 
 
Add Mineralocrticoid antagonist for 8 weeks
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BP response
 
 
 
No BP response
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Subtype classification
 
 
 
 
 
 
 
 
 
• Deoxycorticosterone excess( Tumor, 17 alpha hydroxylase and 11 beta hydroxylase deficiency)
• Licorice ingestion
•Glucocorticoid resistance
 
 
 
Liddle's syndrome)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adrenal CT scan
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal, micornodularity, bilateral masses or unilateral atypical mass
 
 
 
 
 
Unilateral hypodense nodule >1cm and <2cm in the setting of marked primary hyperaldosteronism
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surgery not desired
 
Surgery desired
 
 
Surgery desired
 
 
 
Surgery not desired
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
> 35 years consider
 
< 35 years consider
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• Glucocorticoid-remediable aldosteronism (GRA) OR Idiopathic hyperaldosteronism:
• Pharmacologic therapy
 
Adrenal Venous Sampling
 
Adrenal Venous Sampling
 
Aldosterone Producing Adenoma (APA) or Primary Adrenal Hyperplasia (PAH):
Unilateral laproscopic adrenalectomy
 
Pharmacological therapy